Anti-Anxiety Medications With Side Effect Profiles: A Patient Reference
Reviewed by Daniel Montville, MD, Psychiatrist
SiggyMD Clinical Team · Last updated June 17, 2026
Key Takeaways
- SSRIs and SNRIs are the preferred first-line pharmacological treatments for generalized anxiety disorder, panic disorder, and social anxiety disorder across major clinical guidelines. Their anxiolytic effects develop over 2 to 6 weeks.
- Benzodiazepines provide rapid relief but are structurally time-limited: they lose therapeutic anti-anxiety effect after 4 to 6 months of regular use and carry dependence and withdrawal risks. Guidelines recommend short-term use only, as add-on therapy alongside an SSRI or SNRI.
- Buspirone is FDA-approved for generalized anxiety disorder, has no dependency risk, and takes 10 days to 4 weeks to reach therapeutic effect. It is a meaningful option for patients who cannot tolerate SSRI side effects.
- Hydroxyzine is a prescription antihistamine with FDA approval for anxiety. It works within 30 minutes and carries no dependency risk, making it useful for acute situational anxiety and anxiety-related insomnia.
- Beta-blockers such as propranolol reduce the physical symptoms of anxiety (racing heart, tremor, sweating) but do not address the subjective experience of anxiety. They are used off-label for performance and situational anxiety.
Not all anxiety medications work the same way. Not all of them are meant to be taken every day. Not all of them carry the same risks. And the one your prescriber chooses says something specific about how they have understood your situation.
What most patient-facing resources leave out is the decision logic. Which medication is first-line and why. What the side effects actually look like in practice. What “short-term use only” means for benzodiazepines and why it matters. And what to do when side effects appear between appointments.
This is a reference document. It covers the major classes of anxiety medications, their mechanisms, their clinical uses, and their side effect profiles, organized the way a prescriber thinks about it.
What This Page Covers
- SSRIs and SNRIs as first-line options for anxiety
- Buspirone for generalized anxiety without dependency risk
- Benzodiazepines: effective but structurally time-limited
- Hydroxyzine and beta-blockers for specific situations
- How to talk to your prescriber about side effects
First-Line: SSRIs and SNRIs
Anxiety disorders and depression share overlapping neurobiology, which is why the medications developed to treat depression are now the primary first-line treatments for anxiety disorders.
SSRIs and SNRIs are the preferred first-line pharmacological treatments for generalized anxiety disorder, panic disorder, and social anxiety disorder across major international clinical guidelines. Their anxiolytic effects develop over 2 to 6 weeks through downstream changes in neuroplasticity, BDNF upregulation, and normalization of fear circuitry in the amygdala and prefrontal cortex.
SSRIs work by blocking the serotonin transporter, increasing synaptic serotonin availability. Common SSRIs prescribed for anxiety include sertraline (Zoloft), escitalopram (Lexapro), fluoxetine (Prozac), paroxetine (Paxil), and citalopram (Celexa). Paroxetine and escitalopram have specific FDA approvals for generalized anxiety disorder. Sertraline is commonly used across multiple anxiety disorder types.
SNRIs block both serotonin and norepinephrine reuptake. Venlafaxine (Effexor XR) and duloxetine (Cymbalta) are the most commonly prescribed SNRIs for anxiety. Duloxetine is particularly useful for patients with co-occurring chronic pain or fibromyalgia.
SSRI and SNRI Side Effects
The most common side effects during the first 2 to 4 weeks are nausea, headache, and sleep disturbance. These initial side effects typically subside within 4 to 8 weeks. SSRIs are not addictive but should not be stopped abruptly; gradual tapering under prescriber supervision reduces discontinuation symptoms.
Longer-term side effects that persist in some patients include sexual dysfunction, mild weight changes, and emotional blunting. SNRIs carry an additional risk of elevated blood pressure with dose increases. Both classes have rare but serious risks: serotonin syndrome if combined with other serotonergic agents, and increased bleeding risk in patients taking anticoagulants.
An important clinical reality: SSRIs and SNRIs can temporarily worsen anxiety during the first one to two weeks of treatment due to initial receptor activation before neuroplasticity changes take hold. Patients who stop during that window are often abandoning a medication that would have worked.
Buspirone: Non-Addictive Anxiety Relief
Buspirone (BuSpar) is FDA-approved for generalized anxiety disorder and works as a partial agonist at serotonin 5-HT1A receptors, reducing anxiety through a gradual mechanism rather than sedation.
A Cochrane review found buspirone superior to placebo for GAD, though with a smaller effect size compared to benzodiazepines and with reduced effectiveness in patients with prior benzodiazepine use. It takes approximately 10 days to 4 weeks to reach therapeutic effect, making it unsuitable for acute anxiety situations.
What makes buspirone clinically valuable is what it does not do: it does not cause sedation, does not impair memory or coordination, does not carry dependency risk, and does not produce withdrawal symptoms. For patients with GAD who need ongoing support without the limitations of benzodiazepines or the sexual side effects of SSRIs, buspirone is a meaningful option.
Buspirone Side Effects
Common side effects include dizziness, headache, and nausea, which tend to be mild and often resolve with continued use. Buspirone is dosed two to three times daily, which some patients find inconvenient compared to once-daily alternatives. Buspirone is generally dosed at 15 to 60 mg per day in divided doses.
Benzodiazepines: Effective But Structurally Time-Limited
Benzodiazepines remain the fastest-acting class of anxiety medications. Drugs such as alprazolam (Xanax), clonazepam (Klonopin), lorazepam (Ativan), and diazepam (Valium) enhance the inhibitory neurotransmitter GABA, providing rapid relief of acute anxiety symptoms, with peak blood levels reached 1 to 2 hours after dosing.
They are effective for panic attacks, acute situational anxiety, and anxiety severe enough to prevent engagement with first-line treatments. They are also used short-term to help patients tolerate the initial anxiogenic effects of starting an SSRI or SNRI.
What limits their use is structural. The American Academy of Family Physicians documents that benzodiazepines lose their therapeutic anti-anxiety effect after 4 to 6 months of regular use. Physical dependence develops with sustained use, and withdrawal can be severe if they are stopped abruptly. Cognitive impairment, sedation, falls in older adults, and elevated accident risk are well-established concerns.
Benzodiazepine Side Effects
Sedation, cognitive slowing, impaired coordination, and memory gaps are the most common side effects. These are dose-dependent and more pronounced with higher-potency short-acting agents like alprazolam than with longer-acting agents like clonazepam. Combining benzodiazepines with alcohol, opioids, or other central nervous system depressants is dangerous and can be fatal.
Hydroxyzine: A Prescription Antihistamine With an Anxiolytic Effect
Hydroxyzine (Vistaril, Atarax) is a first-generation antihistamine with FDA approval for anxiety. It works by blocking histamine H1 receptors and has sedating effects that reduce anxiety rapidly, with onset within 30 minutes.
Hydroxyzine is used as a short-term option for acute anxiety and for anxiety-related insomnia. It does not carry dependency or withdrawal risk. A 2020 study found that hydroxyzine may have comparable efficacy to benzodiazepines and buspirone for GAD in some patients.
Hydroxyzine Side Effects
Sedation is the primary effect. Dry mouth, dizziness, and coordination impairment are common. Hydroxyzine is not appropriate for patients who need to drive or operate machinery after dosing. It is generally not used long-term, as its sedating properties make sustained use difficult for most patients’ daily functioning.
Beta-Blockers: Targeting the Physical Symptoms
Beta-blockers such as propranolol (Inderal) and atenolol (Tenormin) do not reduce the subjective experience of anxiety. They reduce the physical symptoms: elevated heart rate, tremor, sweating, and blushing, by blocking beta-adrenergic receptors.
This mechanism makes them useful for situational performance anxiety: a high-stakes presentation, a social event, a medical procedure. Taking propranolol 30 to 60 minutes before a challenging situation can substantially reduce the physical experience of anxiety without sedation or impaired cognition.
Beta-blockers are not FDA-approved for anxiety disorders and are used off-label for this purpose. They are not appropriate for daily management of generalized anxiety.
Beta-Blocker Side Effects
Fatigue, bradycardia, and reduced blood pressure are the most common side effects. Beta-blockers are contraindicated in patients with asthma, COPD, or certain cardiac arrhythmias. Blood glucose monitoring is relevant for diabetic patients, as beta-blockers can mask the symptoms of hypoglycemia.
Talking to Your Prescriber About Side Effects
Side effects are clinical information. A prescriber who knows you stopped taking a medication after three days because of nausea can explain that this particular side effect typically resolves by week three, and the conversation continues. A prescriber who does not know has less to work with.
The most important distinction for a patient experiencing side effects is whether the symptom is likely to resolve, likely to persist, or potentially serious. Nausea on week one of an SSRI is almost always in the first category. Sexual dysfunction at week twelve is usually in the second. Anything that feels like an emergency, including signs of serotonin syndrome (agitation, fever, rapid heartbeat, shaking), should be treated as one: contact your prescriber immediately or call 911 if symptoms are severe.
How SiggyMD Supports Side Effect Management
Side effect monitoring at SiggyMD happens between appointments, not only at the next scheduled one. When a patient logs a side effect through the daily check-in, the clinical team is notified. Education on the specific medication, its mechanism, typical timeline for side effects, and management strategies, is available on demand.
“Side effects are one of the main reasons people stop medication before it has had time to work,” says Daniel Montville, MD, Psychiatrist, of the SiggyMD clinical team. “When I know about a side effect within days of it starting, I can intervene immediately. I can reassure the patient that it is expected and time-limited, or I can adjust the plan if it is not. The check-in data is what makes that possible.”
Your prescriber is always one tap away when a side effect feels like more than you should be managing on your own.
What Members Are Saying
JP
J.P., 38
Generalized Anxiety Disorder
“I stopped my SSRI after two weeks because the nausea was so bad. I thought I was having a bad reaction. My prescriber explained later that what I experienced was normal early-stage activation and would have resolved by week three. I wish I had known that before I stopped. I went back on it six months later and the side effects were mild the second time.”
NC
N.C., 29
Social Anxiety Disorder
“Propranolol before presentations changed my life. I am still anxious in the way that helps me prepare. I am not anxious in the way that makes my hands shake and my voice go flat. My prescriber was the one who suggested it. I did not know it was an option.”
Member stories reflect real experiences. Names and identifying details have been changed to protect privacy. Results vary. SiggyMD is currently invite-only.
Bottom Line
Anti-anxiety medications differ fundamentally in how they work, when they work, and what their long-term profiles look like. SSRIs and SNRIs are the evidence-based first-line options for sustained anxiety management. Buspirone offers a dependency-free alternative for GAD. Benzodiazepines are effective acutely but structurally time-limited. Hydroxyzine and beta-blockers serve specific situational purposes.
The medication that is right for you depends on factors your prescriber needs to understand: what kind of anxiety you have, when it happens, what comorbidities are present, and what you can tolerate. That conversation is clinical and ongoing.
If you are currently managing anxiety and are unsure whether your medication is the right choice, or if side effects are affecting your daily life, a clinician-reviewed treatment plan can provide real clarity. You can also read about how anxiety medication management works between appointments or start your intake with SiggyMD today.
Sources
-
Garakani A, et al. Pharmacotherapy for Anxiety Disorders: From First-Line Options to Treatment Resistance. Frontiers in Psychiatry. 2021;11:595584.
-
Haddad PM. Drugs for anxiety: from chloral hydrate to novel therapeutics. The British Journal of Psychiatry. 2026;228(6):500-503.
-
Drugs.com. List of 54 Anxiety Medications Compared. Accessed June 2026.
-
GoodRx. Medications for Generalized Anxiety Disorder. March 2025.
-
HelpGuide. Anxiety Medication. Accessed June 2026.
-
Medical News Today. Anxiety medication: List, types, and side effects. Accessed June 2026.
Frequently Asked Questions
What is the most commonly prescribed first-line medication for anxiety?
SSRIs and SNRIs are the first-line pharmacological treatments recommended by major guidelines for anxiety disorders including generalized anxiety disorder, panic disorder, and social anxiety disorder. Sertraline, escitalopram, and venlafaxine are among the most frequently prescribed. They require 2 to 6 weeks to reach therapeutic effect but have strong long-term safety profiles without the dependency risks of benzodiazepines.
Are benzodiazepines safe for long-term anxiety treatment?
Clinical guidelines do not recommend benzodiazepines for long-term anxiety management. They lose their therapeutic anti-anxiety effect after 4 to 6 months of regular use, carry dependence and withdrawal risks, and cause cognitive impairment and sedation. Guidelines recommend them only short-term and alongside a longer-term treatment such as an SSRI or SNRI. If you are currently taking a benzodiazepine long-term, talk to your prescriber before making any changes.
What is buspirone used for and is it effective?
Buspirone is FDA-approved for generalized anxiety disorder and works as a partial agonist at serotonin 5-HT1A receptors. A Cochrane review found it superior to placebo for GAD, though with a smaller effect size than benzodiazepines. Its main advantages are no dependence risk, no sedation, and no cognitive impairment. It takes 10 days to 4 weeks to work, which makes it unsuitable for acute anxiety but well-suited for ongoing GAD management.
Can SSRIs make anxiety worse before getting better?
Yes. SSRIs and SNRIs can temporarily increase anxiety, agitation, or jitteriness during the first one to two weeks of treatment. This is a known pharmacological effect caused by initial serotonin receptor activation before longer-term neuroplasticity changes take hold. It is not evidence that the medication is wrong. Most patients who persist through this period see the anxiety normalize by week two to three. Inform your prescriber if the early agitation is severe.
What is hydroxyzine and how is it used for anxiety?
Hydroxyzine (Vistaril) is a prescription antihistamine with FDA approval for anxiety. It works by blocking histamine H1 receptors, producing a calming effect within 30 minutes. It carries no dependency risk. It is typically used for acute or situational anxiety and for anxiety-related sleep difficulty. It is not appropriate for daily long-term anxiety management because its sedating properties make sustained daily use difficult for most people.
Do beta-blockers actually help with anxiety?
Beta-blockers like propranolol reduce the physical symptoms of anxiety: racing heart, sweating, tremor, and blushing. They do not reduce the subjective feeling of anxiety or the cognitive component. This makes them well-suited for performance anxiety situations, where the physical symptoms interfere with functioning, but not for chronic generalized anxiety disorder. They are used off-label for anxiety; they are not FDA-approved for anxiety disorders.
Mental healthcare should stay with you between appointments.
SiggyMD combines daily check-ins with clinician-supervised care so your treatment plan can respond to what is actually happening.
SiggyMD is currently invite-only. A real doctor reviews every clinical decision. HIPAA-compliant.